毒理性
母乳喂养期间使用总结:目前没有关于母乳喂养期间使用拉布立酶的临床信息。由于它是一种大分子蛋白质,分子量约为34,000 Da,母乳中的含量可能非常低,而且由于它可能被婴儿的胃肠道破坏,因此吸收的可能性不大。然而,制造商建议在拉布立酶治疗期间及最后一剂后的2周内停止母乳喂养。
◉ 对哺乳婴儿的影响:截至修订日期,没有找到相关的已发布信息。
◉ 对泌乳和母乳的影响:截至修订日期,没有找到相关的已发布信息。
◉ Summary of Use during Lactation:No information is available on the clinical use of rasburicase during breastfeeding. Because it is a large protein molecule with a molecular weight of about 34,000 Da, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. However, the manufacturer recommends that breastfeeding be discontinued during rasburicase therapy and for 2 weeks after the final dose.
◉ Effects in Breastfed Infants:Relevant published information was not found as of the revision date.
◉ Effects on Lactation and Breastmilk:Relevant published information was not found as of the revision date.
来源:Drugs and Lactation Database (LactMed)